Prehabilitation for older adults undergoing lung cancer surgery should emphasize activities of daily living, self-care, ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

This blog describes a typical ILD patient journey from the initial diagnosis through its long-term management to end-of-life ...

Ioannis Sapountzis, head of global therapeutic areas at Boehringer, said that FIBRONEER-IPF is the largest trial in IPF ...

In addition to pulmonary fibrosis, columnist Ann Reynoso is now also dealing with sleep apnea — both of which affect her ...

Living with IPF has brought many emotional ups and downs for columnist Sam Kirton, and recent events have caused him to hit ...

Among patients with PPF, those treated with 60 mg of admilparant showed significant decreases in periostin, ferritin, and ...

Topline data from FIBRONEER-IPF show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in Forced Vital Capacity [mL] at week 52 vers ...

R&D image Topline data from FIBRONEER™-IPF show that the investigational compound nerandomilast met its primary endpoint, ...

We are shedding a spotlight on September being Pulmonary Fibrosis Month. I got to speak once again with 4-Time World Series ...

Researchers say machine learning advances make it possible to use more sophisticated body composition analyses to assess risk ...